[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365698-105":59,"doc-detail-365698-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cost-utility-and-clinical-impact-of-endoscopic-screening-for-esophageal-and-gastric-neoplasia-in-patients-with-head-and-neck-neoplasms","Cost-utility and clinical impact of endoscopic screening for esophageal and gastric neoplasia in patients with head and neck neoplasms","","Patients with head and neck neoplasms face elevated risks of esophageal neoplasia and gastric neoplasia, motivating evaluation of whether endoscopic screening adds meaningful clinical benefit in Western practice. A single-center cohort study assessed screening with esophagogastroduodenoscopy, measuring detection frequency, clinical and pathological outcomes, and subsequent treatments. Cost-utility was modeled from a societal perspective using a Markov framework with probabilistic sensitivity analysis. Incremental cost-effectiveness supported affordability while most detected lesions were early-stage and treated endoscopically.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cost-utility-and-clinical-impact-of-endoscopic-screening-for-esophageal-and-gastric-neoplasia-in-patients-with-head-and-neck-neoplasms/365698/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cost-utility-and-clinical-impact-of-endoscopic-screening-for-esophageal-and-gastric-neoplasia-in-patients-with-head-and-neck-neoplasms/365698.png","ImageObject",300,407,{"name":92,"@type":93},"Alex Sinclair","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What patient population was studied for endoscopic screening?","Question",{"text":112,"@type":113},"Patients with head and neck neoplasms eligible for curative treatment in a single-center Western setting underwent esophagogastroduodenoscopy screening.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were esophageal and gastric lesions evaluated and what were the main outcomes?",{"text":117,"@type":113},"The study assessed the frequency of detected esophageal and gastric neoplasia and their clinical and pathological outcomes, including stage and treatments such as endoscopic resection.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the screening strategy perform in terms of cost-effectiveness?",{"text":121,"@type":113},"The screening approach showed an incremental cost-effectiveness ratio of 39,357.8 €/quality-adjusted life years gained and remained cost-effective under sensitivity analyses using prevalence estimates from multiple Western countries.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},365698,1790783176,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Original article    \nCost-utility and clinical impact of endoscopic screening for esophageal and gastric neoplasia in patients with head and neck neoplasms  \nRui Moraisa ,b ,* , João Afonsoa ,b ,* , Nuno Sousaa ,b , Bernardo Sousa-Pintoc ,d , Diogo Libânioc ,e , Bárbara Marinhob , Maria Luísa Sacramentob ,f , Mariana Simplíciob ,f , Isabel Faria-Ramosf , Luís Azevedog , Margarida Marquesa ,b , Helena Silveirab ,h , Irene Gullob ,f, i , Fátima Carneirob ,f, i , João Santos-Antunesa ,b , i ,† and Guilherme Macedoa ,b ,†  \n\n| Objective Patients with head and neck neoplasms (HNN) are at an increased risk of esophageal neoplasia (EN) and gastric neoplasia (GN) . We aimed to assess the clinical impact and cost-utility of endoscopic screening in this population in the Western setting.\u003Cbr>Methods In this single-center study HNN patients eligible for curative treatment underwent screening |\n| --- |\n| esophagogastroduodenoscopy. We assessed the frequency, clinical, and pathological outcomes of EN and GN. The costeffectiveness of an annual endoscopic screening for EN was evaluated from a societal perspective, using a Markov model and probabilistic sensitivity analysis. In addition, we performed a sensitivity analysis using data on the prevalence of detected EN lesions in the four largest previous Western studies on this topic.\u003Cbr>Results Forty-six HNN patients met the inclusion criteria and underwent endoscopic screening. Six EN were detected in five patients (10 .9%, 95% confidence interval: 1.9–19.9%) . Additionally, five GN were detected in five patients. Most patients had early-stage EN or GN (90%) and were treated with endoscopic resection (80%) . Endoscopic screening strategy had an incremental cost-effectiveness ratio of 39 357.8 €/quality-adjusted life years gained, being cost-effective at a willingness-topay threshold of two times the Portuguese gross domestic product per capita. In the sensitivity analysis, it remained costeffective when considering the prevalence of EN reported in Germany, France, and Brazil.\u003Cbr>Conclusion An endoscopic screening program identified EN or GN in a fifth of HNN patients, most presenting at an early stage. The program implementation appears to be cost-effective in Portugal. These results may be applicable to other medium-to-high-income Western countries. Eur J Gastroenterol Hepatol 37 : 815–825\u003Cbr> Copyright © 2025 The Author(s) . Published by Wolters Kluwer Health, Inc.  |\n\nEuropean Journal of Gastroenterology & Hepatology 2025, 37:815–825 Keywords: cost-effectiveness analysis, cost-utility analysis, esophageal neoplasia, esophagogastroduodenoscopy, gastric neoplasia, head and neck neoplasms, screening  \naDepartment of Gastroenterology, Unidade Local de Saúde São João, bFaculty of Medicine, cMEDCIDS, Department of Community Medicine, Information and Health Decision Sciences, dCINTESIS@RISE-Health Research Network, Faculty of Medicine, University of Porto, eGastroenterology Department, RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) and Porto Comprehensive Cancer Center (Porto CCC), fDepartment of Pathology, gAutonomous Management Unit, hDepartment of Otorhinolaryngology and Head and Neck Surgery, Unidade Local de Saúde São João and iIPATIMUP/ i3S, University of Porto, Porto, Portugal  \nCorrespondence to Rui Morais, MD, Gastroenterology Department, Unidade Local de Saúde São João, 4200-319 Porto, Portugal  \nTel: +351 919460418; e-mail: [ruimorais20@gmail.com](ruimorais20@gmail.com)  \n*Rui Morais and João Afonso contributed equally to the writing of this article.†João Santos-Antunes and Guilherme Macedo contributed equally to the writing of this article and share senior authorship.  \nThis is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBYNC-ND) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or","cbCaigZq2qwIAZ6x","https://ap.wps.com/l/cbCaigZq2qwIAZ6x","pdf",700919,11,"English","# Objective\n# Methods\n## Screening procedure and outcomes\n## Cost-utility modeling and sensitivity analyses\n# Results\n## Detection rates and stage distribution\n## Cost-effectiveness findings\n# Conclusion\n# Introduction\n## Rationale for gastroesophageal screening\n## Rationale for esophageal screening in high-risk groups\n# Patients with head and neck neoplasms: risk and rationale for early detection","[{\"question\":\"What patient population was studied for endoscopic screening?\",\"answer\":\"Patients with head and neck neoplasms eligible for curative treatment in a single-center Western setting underwent esophagogastroduodenoscopy screening.\"},{\"question\":\"How were esophageal and gastric lesions evaluated and what were the main outcomes?\",\"answer\":\"The study assessed the frequency of detected esophageal and gastric neoplasia and their clinical and pathological outcomes, including stage and treatments such as endoscopic resection.\"},{\"question\":\"How did the screening strategy perform in terms of cost-effectiveness?\",\"answer\":\"The screening approach showed an incremental cost-effectiveness ratio of 39,357.8 €/quality-adjusted life years gained and remained cost-effective under sensitivity analyses using prevalence estimates from multiple Western countries.\"}]","Cost-utility and clinical impact of endoscopic screening for esophageal and gastric neoplasia in patients with head and neck neoplasms | PDF",1790161857,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8ed6a25c80e0d865bb74424345d22c1.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad53b6fe901b1670898deb0c26d49600.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ea55b4f29dc8ab8f38d36bae23326e3.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b606e62aab2b573053823126ccfcdd0b.webp",980,1306]